Research progress of RNA drugs delivery
10.16438/j.0513-4870.2022-0500
- VernacularTitle:RNA药物递送研究进展
- Author:
Dan LI
;
Yu-kun HUANG
;
Xiao-ling GAO
- Publication Type:Research Article
- Keywords:
messenger RNA;
small interfering RNA;
microRNA;
antisense oligonucleotide;
rug delivery system
- From:
Acta Pharmaceutica Sinica
2023;58(3):469-482
- CountryChina
- Language:Chinese
-
Abstract:
Ribonucleic acid (RNA) medicines have strong therapeutic potential for numerous rare genetic illnesses and malignancies because of its exact programmability based on Watson-Crick base pairing principle and unique ability to regulate gene expression. However, RNA medicines still have limitations in many areas, including stability, half-life time, immunogenicity, organ selectivity, cellular uptake and endosomal escape efficiency despite their great therapeutic potentials. This review briefly introduced numerous RNA medications [mostly messenger RNA (mRNA), small interfering RNA (siRNA), microRNA (miRNA) and antisense oligonucleotide (ASO)] that have intrigued of researchers in recent years, as well as their action mechanism in vivo. A number of delivery techniques, such as chemical modification, ligands coupling and nanocarriers have been proposed. The manufacture and applications of lipid nanoparticle, polymer nanoparticle and exosomes were discussed in depth. The goal of this work is to give a theoretical foundation and design concepts for the development of effective and safe RNA delivery technology, as well as to facilitate RNA therapeutic clinical translation.
